Robert W. Duggan, Director, 10% Owner at Pulse Biosciences, Inc. (PLSE), bought 20,241 shares at $6.09 ($123K) on 2023-11-17, disclosed to the SEC on 2023-11-20.
Open-market purchase of $123k PLSE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.09 | 10,000 | $61K | 49.3% |
| 2 | $6.10 | 241 | $1K | 1.2% |
| 3 | $6.11 | 10,000 | $61K | 49.5% |
| Total | $6.10 avg | 20,241 | $123K | 100% |
| Filing → |
| PLSE | BUY | 2026-05-11 | $13.0M | — | Filing → |
| SMMT | BUY | 2025-10-23 | $1000K | — | Filing → |
| PLSE | BUY | 2025-09-12 | $5.4M | — | Filing → |